Concepedia

Kevin M. Peese

KM

Statistics

Publications

12

Citations

679

H-Index

12

Active since

2003

Affiliations

Bristol-Myers Squibb (United States)(Current)

Pfizer (United States)

University of Illinois Urbana-Champaign

GlaxoSmithKline (United States)

Kevin M. Peese is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

2003–2023

12

Publications

12

Glutathione S-Transferase Omega 1-1 Is a Target of Cytokine Release Inhibitory Drugs and May Be Responsible for Their Effect on Interleukin-1औ Posttranslational Processing

Ronald E. Laliberte, David G. Perregaux, Lise R. Hoth et al. · Journal of Biological Chemistry · 2003 · 208 citations · Full text

, , +11

Efficient Synthetic Access to the Hetisine C<sub>20</sub>-Diterpenoid Alkaloids. A Concise Synthesis of Nominine via Oxidoisoquinolinium-1,3-Dipolar and Dienamine-Diels−Alder Cycloadditions

Kevin M. Peese, David Y. Gin · Journal of the American Chemical Society · 2006 · 118 citations · Full text

, , +11

Asymmetric Synthetic Access to the Hetisine Alkaloids: Total Synthesis of (+)‐Nominine

Kevin M. Peese, David Y. Gin · Chemistry - A European Journal · 2007 · 95 citations · Full text

, , +16

Enantioselective Approach to the Hetisine Alkaloids. Synthesis of the 3-Methyl-1-aza-tricyclo[5.2.1.0<sup>3,8</sup>]decane Core via Intramolecular Dipolar Cycloaddition

Kevin M. Peese, David Y. Gin · Organic Letters · 2005 · 43 citations · Full text

, , +16

5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors

Kevin M. Peese, Christopher W. Allard, Timothy P. Connolly et al. · Journal of Medicinal Chemistry · 2019 · 36 citations

, , +17

1–5 of 12